keragelT® is a keratin enriched gel that can be used in the regular management of acute and chronic wounds of people caused by conditions similar to epidermolysis bullosa. keragelT® is a low viscosity gel designed to be easy to apply to delicate skin. Some patients and their families using keragelT® as part of daily wound management have shared their stories, find out more.
Correct usage of keragelT® is important to get maximum benefit and make wound and skin management as easy as possible.
- Daily application of keragelT® is recommended for at least one month to observe the potential benefits associated with using the product.
- Arterial ulcers
- keragelT® is recommended for use both on intact skin (to improve its robustness) and on open wounds (to accelerate their healing).
- keragelT® can be combined with common emollient creams and incorporated into daily skin management. This can be a convenient way to use the product and may also help reduce stickyness as the product dries.
Epidermolysis Bullosa (EB) is a rare genetic disease characterized by the presence of extremely fragile skin and recurrent blister formation, resulting from minor mechanical friction or trauma. Molecular Biologicals is proud to work closely with the epidermolysis bullosa community in the US and other regions of the world, and with the global organization DEBRA.
Through regular use of our advanced keratin enriched wound healing products, many families, their health care providers, dermatologists, and primary care physicians have reported benefits in children and adults suffering from a variety of acute and chronic wounds that can be caused by conditions similar to epidermolysis bullosa.